Yufei Xiang

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 4

Top Topics

Respiratory Syndrome Coronavirus

Angiotensin Converting Enzyme

Top Venues

Proceedings of the National Academy of Sciences of the United States of America

Science advances

Science (New York, N.Y.)

Nature communications

Carnegie Mellon University (MSC)

This page only lists publications with an associated author ORCID identifier.

Education History

Carnegie Mellon University

United States

MSC :: Biomedical Engineering

Publications

Haibo Yang, Yumin Wang, Yufei Xiang, Tribhuwan Yadav, Jian Ouyang, Laiyee Phoon, Xueping Zhu, Yi Shi, Lee Zou, Li Lan
FMRP promotes transcription-coupled homologous recombination via facilitating TET1-mediated m5C RNA modification demethylation. Proceedings of the National Academy of Sciences of the United States of America 119 (12) (2022)
Sham Nambulli, Yufei Xiang, Natasha Louise Tilston-Lunel, Linda J Rennick, Zhe Sang, William B Klimstra, Douglas S Reed, Nicholas A Crossland, Yi Shi, W Paul Duprex
Inhalable Nanobody (PiN-21) prevents and treats SARS-CoV-2 infections in Syrian hamsters at ultra-low doses. Science advances 7 (22) (2021)
Dapeng Sun, Zhe Sang, Yong Joon Kim, Yufei Xiang, Tomer Cohen, Anna K Belford, Alexis Huet, James F Conway, Ji Sun, Derek J Taylor, Dina Schneidman-Duhovny, Cheng Zhang, Wei Huang, Yi Shi
Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting diverse and conserved epitopes. Nature communications 12 (1) (2021)
Yufei Xiang, Sham Nambulli, Zhengyun Xiao, Heng Liu, Zhe Sang, W Paul Duprex, Dina Schneidman-Duhovny, Cheng Zhang, Yi Shi
Versatile and multivalent nanobodies efficiently neutralize SARS-CoV-2. Science (New York, N.Y.) 370 (6523) (2020)